MYGN · Myriad Genetics, Inc.
AI read · Neutral
The AI's read
The change is a less negative view from Piper Sandler, but Neutral is not a positive rating. Its $5 target keeps the call cautious. The story reports no change to Myriad's sales, products, or operations, so it does not change the company's business outlook.